Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.

Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.

JAMA. 2004 May 26;291(20):2433-40.

PMID:
15161893
2.

Aspirin and NSAIDs: effects in breast and ovarian cancers.

Crew KD, Neugut AI.

Curr Opin Obstet Gynecol. 2006 Feb;18(1):71-5. Review.

PMID:
16493264
3.
4.

Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.

Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Int J Cancer. 2013 Mar 1;132(5):1146-55. doi: 10.1002/ijc.27717. Epub 2012 Jul 27. Review.

5.

NSAIDs and breast cancer: a possible prevention and treatment strategy.

Agrawal A, Fentiman IS.

Int J Clin Pract. 2008 Mar;62(3):444-9. doi: 10.1111/j.1742-1241.2007.01668.x. Epub 2008 Jan 8. Review.

PMID:
18194278
6.

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG.

Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15. Review.

PMID:
20844293
7.

Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.

Muranushi C, Olsen CM, Pandeya N, Green AC.

J Invest Dermatol. 2015 Apr;135(4):975-983. doi: 10.1038/jid.2014.531. Epub 2014 Dec 18. Review.

8.

Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.

Muranushi C, Olsen CM, Green AC, Pandeya N.

J Am Acad Dermatol. 2016 Jan;74(1):108-119.e1. doi: 10.1016/j.jaad.2015.08.034. Epub 2015 Oct 1. Review.

PMID:
26433247
9.

NSAIDs and gastrointestinal cancer prevention.

Jolly K, Cheng KK, Langman MJ.

Drugs. 2002;62(6):945-56. Review.

PMID:
11929340
10.

Can Aspirin Reduce the Risk of Endometrial Cancer?: A Systematic Review and Meta-analysis of Observational Studies.

Zhang D, Bai B, Xi Y, Zhao Y.

Int J Gynecol Cancer. 2016 Jul;26(6):1111-20. doi: 10.1097/IGC.0000000000000731. Review.

PMID:
27177285
11.

The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.

Moris D, Kontos M, Spartalis E, Fentiman IS.

Breast Care (Basel). 2016 Oct;11(5):339-344. Epub 2016 Oct 24. Review.

12.

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates.

Suzuki Y, Inoue T, Ra C.

Pharmaceuticals (Basel). 2010 May 19;3(5):1594-1613. Review.

13.

Aspirin and urologic cancer risk: an update.

Bosetti C, Rosato V, Gallus S, La Vecchia C.

Nat Rev Urol. 2012 Jan 24;9(2):102-10. doi: 10.1038/nrurol.2011.219. Review.

PMID:
22270135
14.

The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.

Horn SL, Fentiman IS.

Pharmaceuticals (Basel). 2010 May 17;3(5):1550-1560. Review.

Supplemental Content

Support Center